Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00341172 · ClinicalTrials.gov registry record
The Effects of Genetic Differences Among AIDS Patients on Cytomegalovirus Retinitis
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 2,232
- Enrollment target
NCT00341172: Completed study, sponsored by National Cancer Institute (NCI).
NCT00341172 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 2,232 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00341172 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 2,232 participants
- Enrollment target
Study Summary
This study will evaluate the role of certain gene variants on the onset and course of cytomegalovirus (CMV) retinitis-a severe infection affecting the eye-in patients with AIDS. Symptoms include blurry vision, eye pain, photophobia, floaters, eye redness, and impaired vision. Left untreated, it can cause blindness. The study is done in collaboration with investigators of the Longitudinal Studies of the Ocular Complications of AIDS (LSOCA) at the Johns Hopkins University School of Medicine. The purpose of the LSOCA study is to learn about how HIV and other infections associated with AIDS and their treatments affect people's eyes and sight. Blood samples previously collected from patients participating in the LSOCA study will be analyzed for gene variants. These differences will then be correlated with the patients' clinical data to try to discover the role of gene differences among patients on the following: susceptibility to CMV and related problems; development and course of CMV; and response to HAART (highly active antiretroviral treatment), particularly in CMV onset and pathology. The study will use blood samples and clinical information previously collected from patients during their participation in LSOCA. The materials will be identified with a numerical code linking the samples and clinical data. No additional procedures will be performed on patients for this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,232 participants |
| Start Date | 2004-10-26 |
| Est. Completion | 2021-03-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00341172
The ClinicalTrials.gov registry entry for NCT00341172 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,232 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00341172 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00341172 about?
NCT00341172 is a clinical study titled "The Effects of Genetic Differences Among AIDS Patients on Cytomegalovirus Retinitis". This study will evaluate the role of certain gene variants on the onset and course of cytomegalovirus (CMV) retinitis-a severe infection affecting the eye-in patients with AIDS. Symptoms include blurry vision, eye pain, photophobia, floaters, eye redness, and impaired vision. Left untreated, it can ...
What is the current status of trial NCT00341172?
This trial is currently completed. The enrollment target is 2,232 participants. The study started on 2004-10-26. Estimated completion is 2021-03-04.
Who is sponsoring clinical trial NCT00341172?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.